Clinical Trial Update: Study of the Safety and Efficacy of TH-302 in Combination With Gemcitabine Compared With Gemcitabine Alone in Previously Untreated Patients With Pancreatic Adenocarcinoma [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated evofosfamide (TH-302) with gemcitabine versus gemcitabine alone in patients with previously untreated pancreatic adenocarcinoma. Re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• Gemcitabine (Gemcitabine)
• TH-302 (evofosfamide)

Snippet

Sponsor: ImmunoGenesis | Conditions: Pancreatic Adenocarcinoma | Phase 2 | Status: COMPLETED | Results posted: 2017-10-25